Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Where
Changsha
Age
18 years to 75 years
People
41
Run by
Hunan Cancer Hospital
See details and how to joinNCT05940532
Phase 2Taking people
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
Where
Beijing, Fuzhou, Shanghai, Taiyuan, Tianjin, Weifang
Age
18 years to 80 years
People
58
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT05913089
No phaseNot yet taking people in China
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
Where
Beijing
Age
18 years to 80 years
People
100
Run by
Peking University Third Hospital
See details and how to joinNCT05802654
No phaseTaking people
Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
Where
Shanghai
Age
18 years and over
People
2,000
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05857800
Phase 3Not yet taking people in China
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
Where
Shang'ai
Age
18 years to 70 years
People
348
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05496166
Phase 2Taking people
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
40
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT04539977
Phase 2Taking people
Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
Where
Guandong
Age
18 years to 80 years
People
57
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT05825443
No phaseNot yet taking people in China
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
Where
Changsha
Age
18 years to 75 years
People
50
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05822284
Phase 1/2Taking people
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
Where
Shanghai
Age
18 years to 75 years
People
140
Run by
Shanghai Chest Hospital
See details and how to joinNCT05271916
No phaseTaking people
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Where
Guangzhou
Age
18 years to 85 years
People
1,000
Run by
Sun Yat-sen University
See details and how to joinNCT01994057
Phase 3Not yet taking people in China
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
Where
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Hohhot, Jinan, Jining, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Taizhou, Tianjin, Wuhan, Wuhu, Xiamen, Xian, Zhengzhou, Zhenzhou, Zhongshan
Age
18 years and over
People
350
Run by
Suzhou Puhe Pharmaceutical Technology Co., LTD
See details and how to joinNCT05767892
Phase 3Taking people
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
300
Run by
Shanghai Cancer Hospital, China
See details and how to joinNCT05800223
Phase 2Taking people
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Where
Guanzhou
Age
18 years and over
People
30
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT05800340
No phaseTaking people
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
Where
Changsha
Age
18 years to 75 years
People
50
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05778253
Phase 2Taking people
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC
Where
Zhengzhou
Age
18 years to 80 years
People
60
Run by
The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT05286957
Phase 2Taking people
Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
Where
Tianjin
Age
18 years and over
People
65
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT05686434
No phaseTaking people
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
Where
Yiwu
Age
18 years to 80 years
People
200
Run by
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
See details and how to joinNCT05636605
No phaseTaking people
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Where
Jinan
Age
18 years to 85 years
People
350
Run by
The Second Hospital of Shandong University
See details and how to joinNCT04451473
No phaseTaking people
Self-reported Outcomes of Patients in ERAS Nursing
Where
Jinan
Age
18 years to 85 years
People
600
Run by
The Second Hospital of Shandong University
See details and how to joinNCT05528484
Phase 2Taking people
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Where
Beijing, Chongqing, Foshan, Fuzhou, Guangzhou, Guanzhou, Hangzhou, Hefei, Hohhot, Qingdao, Shanghai, Shenzhen, Wuhan, Xiamen, Zhongshan
Age
18 years to 80 years
People
180
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT05536505
No phaseTaking people
Patient's Whole Process Follow-up Management(HOPE-1)
Where
Jinan
Age
18 years and over
People
1,268
Run by
Qianfoshan Hospital
See details and how to joinNCT05339568
Phase 2Taking people
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
Where
Changchun, Chengdu, Dongguan, Dongyang, Foshan, Guangzhou, Hangzhou, Jiangmen, Jinhua, Mianyang, Nanchang, Shenyang, Shijiazhuang, Ürümqi, Wenzhou, Wuhan, Wuhu, Xi'an, Xi’an, Xuzhou, Zhengzhou
Age
18 years and over
People
280
Run by
Sun Yat-sen University
See details and how to joinNCT05334277
Phase 1/2Taking people
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Where
Beijing
Age
18 years and over
People
360
Run by
Xuanzhu Biopharmaceutical Co., Ltd.
See details and how to joinNCT04996121
Phase 2Taking people
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Where
Shanghai
Age
18 years and over
People
96
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05503667
No phaseTaking people
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
Where
Beijing
Age
18 years and over
People
490
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05498064